NCT04272216 2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
Clinical Trials
6 trialsNCT00415246 2019-11-22
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
Ipsen
Phase 3 Terminated
NCT03053635 2018-08-20
Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients
TheralaseĀ® Technologies Inc.
Phase 1 Completed
NCT00827177 2014-01-24
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed
NCT00305929 2010-06-02
Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure
STEBA France
Phase 2 Completed
NCT00312442 2010-06-02
Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
STEBA France
Phase 2/3 Terminated